TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (Q3)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | 7.50%-677.5M | ---- | 15.45%-732.42M | ---- | 71.47%-866.31M | ---- | -479.85%-3.04B | ---- | -93.17%-143.56M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -5.53%-29.67M | ---- | -18.48%-28.11M | ---- | -538.73%-23.73M | ---- | -495.35%-3.72M | ---- | 37.77%-201K |
Impairment and provisions: | ---- | 1,134.98%122.04M | ---- | 137.66%9.88M | ---- | 46.25%4.16M | ---- | 112.16%2.84M | ---- | --1.93M |
-Impairmen of inventory (reversal) | ---- | 1,044.70%113.12M | ---- | 137.66%9.88M | ---- | 46.25%4.16M | ---- | 112.16%2.84M | ---- | --1.93M |
-Other impairments and provisions | ---- | --8.92M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | 72.99%-1.34M | ---- | 80.42%-4.95M | ---- | -101.28%-25.3M | ---- | 45,553.73%1.98B | ---- | ---384K |
-Other fair value changes | ---- | 72.99%-1.34M | ---- | 80.42%-4.95M | ---- | -101.28%-25.3M | ---- | 45,553.73%1.98B | ---- | ---384K |
Asset sale loss (gain): | ---- | 96.57%13.05M | ---- | 140.73%6.64M | ---- | -3,058.62%-16.3M | ---- | 654.79%551K | ---- | 45.00%29K |
-Loss (gain) on sale of property, machinery and equipment | ---- | 590.39%16.96M | ---- | 1,080.77%2.46M | ---- | -62.25%208K | ---- | 654.79%551K | ---- | 45.00%29K |
-Loss (gain) from selling other assets | ---- | -193.31%-3.9M | ---- | 125.34%4.18M | ---- | ---16.51M | ---- | ---- | ---- | ---- |
Depreciation and amortization: | ---- | 43.24%76.89M | ---- | -11.64%53.68M | ---- | 20.32%60.75M | ---- | 24.24%50.49M | ---- | 17.94%11.27M |
-Amortization of intangible assets | ---- | -21.29%20.66M | ---- | 2.97%26.25M | ---- | 25.15%25.5M | ---- | 76.92%20.37M | ---- | 54.71%3.89M |
Financial expense | ---- | -68.91%888K | ---- | 20.91%2.86M | ---- | -47.28%2.36M | ---- | 139.06%4.48M | ---- | 147.82%1.36M |
Exchange Loss (gain) | ---- | 90.70%-3.48M | ---- | -154.82%-37.39M | ---- | -61.51%68.21M | ---- | 17,387.71%177.2M | ---- | -3,352.94%-553K |
Special items | ---- | 28.45%57.22M | ---- | -62.88%44.55M | ---- | -52.77%120M | ---- | 142.94%254.11M | ---- | 3,097.15%26.26M |
Operating profit before the change of operating capital | ---- | 35.52%-441.9M | ---- | -1.35%-685.28M | ---- | -18.17%-676.15M | ---- | -53.63%-572.19M | ---- | -58.84%-103.85M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 268.01%7.91M | ---- | 78.94%-4.71M | ---- | -191.63%-22.34M | ---- | -459.53%-7.66M | ---- | 155.21%1.67M |
Accounts receivable (increase)decrease | ---- | -90.83%9.62M | ---- | 16,998.07%104.94M | ---- | 99.29%-621K | ---- | -6,512.52%-87.68M | ---- | -182.66%-10.21M |
Accounts payable increase (decrease) | ---- | -6.59%-23.3M | ---- | -142.28%-21.86M | ---- | 163.50%51.71M | ---- | -136.61%-81.42M | ---- | 196.49%17.3M |
Special items for working capital changes | --1.15M | -76.22%282K | ---- | 2,012.90%1.19M | ---- | 99.85%-62K | ---- | -199.71%-41.48M | ---- | 61.98%-373K |
Cash from business operations | 32.65%-163.28M | 26.14%-447.39M | 25.47%-242.43M | 6.45%-605.72M | -3.65%-325.26M | 18.09%-647.47M | 26.27%-313.81M | -611.12%-790.43M | ---425.61M | -27.36%-95.46M |
Interest received - operating | 26.98%14.9M | -20.79%22.27M | -10.12%11.73M | 18.48%28.11M | 75.29%13.05M | 538.73%23.73M | 1,101.13%7.45M | 495.35%3.72M | --620K | -37.77%201K |
Special items of business | --1.15M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net cash from operations | 36.18%-147.23M | 26.40%-425.12M | 26.11%-230.69M | 7.40%-577.61M | -1.91%-312.21M | 20.72%-623.74M | 27.91%-306.36M | -611.77%-786.72M | ---424.99M | -27.64%-95.26M |
Cash flow from investment activities | ||||||||||
Decrease in deposits (increase) | ---909.64M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | 110.36%5.77M | 46,706.67%7.02M | 1,915.44%2.74M | -97.59%15K | 750.00%136K | 1,171.43%623K | -98.88%16K | --49K | --1.43M | --40K |
Purchase of fixed assets | 67.97%-572K | 88.56%-1.03M | 81.13%-1.79M | 80.55%-9.04M | 64.81%-9.46M | -64.10%-46.47M | -187.44%-26.9M | -37.51%-28.32M | ---9.36M | 20.03%-6.06M |
Purchase of intangible assets | ---- | ---- | ---- | 84.29%-3.92M | 95.19%-1.03M | 64.38%-24.92M | -671.56%-21.43M | -851.54%-69.98M | ---2.78M | -1,553.08%-2.15M |
Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | --7.49B | --7.49B | ---- | ---- | ---- |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---7.47B | ---7.47B | ---- | ---- | ---- |
Net cash from investment operations | -94,806.07%-904.44M | 146.27%5.99M | 109.22%955K | 76.15%-12.94M | 67.43%-10.36M | 44.77%-54.26M | -197.18%-31.8M | -141.52%-98.24M | ---10.7M | -5.98%-8.17M |
Net cash before financing | -357.77%-1.05B | 29.03%-419.13M | 28.78%-229.74M | 12.90%-590.55M | 4.61%-322.57M | 23.39%-678M | 22.38%-338.17M | -485.27%-884.96M | ---435.7M | -25.61%-103.43M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | 7.94%69.3M | 100.87%69.3M | --64.2M | --34.5M | ---- | ---- | ---- |
Refund | ---- | ---- | ---- | -186.96%-99M | -186.96%-99M | ---34.5M | ---34.5M | ---- | ---- | ---- |
Issuing shares | --1K | --2K | ---- | ---- | ---- | -99.93%2.72M | ---- | 334.36%3.75B | --1.17B | --48.79M |
Interest paid - financing | 83.30%-97K | 68.91%-888K | 65.04%-581K | -20.91%-2.86M | -42.05%-1.66M | -16.30%-2.36M | -17.12%-1.17M | 2.87%-2.03M | ---999K | 8.18%-505K |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---5.13M | ---4.89M | ---- | ---- | 80.99%-109.21M | ---- | ---- |
Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --119.98M | ---- | ---- |
Net cash from financing operations | 19.89%-3.01M | 88.11%-6.82M | 91.17%-3.76M | -426.61%-57.39M | -840.16%-42.58M | -99.53%17.57M | -100.39%-4.53M | 1,242.12%3.74B | --1.16B | 2,801.35%46.19M |
Effect of rate | -47.69%3.54M | -92.41%2.73M | -70.19%6.76M | 152.43%36M | 387.16%22.69M | 61.25%-68.67M | -160.20%-7.9M | -17,387.71%-177.2M | --13.12M | 3,352.94%553K |
Net Cash | -351.69%-1.05B | 34.26%-425.96M | 36.05%-233.5M | 1.89%-647.94M | -6.55%-365.15M | -123.15%-660.43M | -147.18%-342.69M | 2,140.84%2.85B | --726.29M | 31.90%-57.24M |
Begining period cash | -26.64%1.17B | -27.81%1.59B | -27.81%1.59B | -24.89%2.2B | -24.89%2.2B | 1,055.63%2.93B | 1,055.63%2.93B | 102.56%253.52M | --253.52M | 102.56%253.52M |
Cash at the end | -91.61%114.34M | -26.64%1.17B | -26.70%1.36B | -27.81%1.59B | -27.95%1.86B | -24.89%2.2B | 159.75%2.58B | 1,055.63%2.93B | --992.93M | 379.05%196.84M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.